I am not "defensive". I just try to be accurate. They do not "ignore" earlier cases. Rather they work with those cases they know about.
You put a lot of weight into Worobey's report because it's the main source of specific spillover evidence. But it really isn't any stronger than what we already know about the spillover hypothesis. There is still no animal source and no outbreaks anywhere else except Wuhan where these viruses were being studied and that included live cultures, a fact that I believe was denied at first. '
Of all the gin joints in China ...'
Which specific cases are being "ignored"?
The ones China at first admitted to then later refused to share any of the demographic data about. Demographic as in the things an epidemiologist would look at to track down the source of an outbreak.
Worobey used convenient confirmation bias data that was readily available. He ignored the rest. Quay used a similar approach noting that the hospitals taking COVID patients followed the metro line that connected the WIV to the city proper and you dismissed that analysis out of hand. Interestingly some of the the hospitals are near the market as well.
Wherever data was missing Worobey chalked it up to asymptomatic and mild cases. That's valid
if you have dots to connect the cases. In Seattle and surroundings researchers at Fred Hutch (Bloom's lab) connected the dots between the first known patient who had come straight from Wuhan, to a Seattle resident that was picked up in a flu surveillance study, and to an outbreak at the nursing home near me. We don't know who passed the virus on in between, but the genetics showed the cases were connected.
Worobey concluded A&B lineages represented 2 separate spillover events both occurring at the seafood market. Other researchers think the A&B lineages have a direct connection with B being a variant of A.
Here's an example of fitting the evidence to existing bias:
Paper by Worobey in Science: Dissecting the early COVID-19 cases in Wuhan
Samples from the earliest COVID-19 patients in Wuhan have been sequenced, and two distinct SARS-CoV-2 lineages, A and B, have been identified. Given that the elderly couple at HPHICWM was the WHO report’s cluster 1, it follows that the husband, illness onset 26 December (1), must be the source of the earliest lineage A sequence, Wuhan/IME-WH01/2019 (GenBank accession number MT291826) (see fig. S1), which he most likely got from his wife, who became ill 15 December. This raises the possibility that the Yangchahu Market that they visited may have been a site of a separate animal spillover.
Yes the earliest cases we have genome and other demographic data for. In the paper he uses the fact the hospital that had this patient was the first to identify the virus and raise the alarm. This was about the same time the Chinese had suppressed the ophthalmologist who reported seeing several cases of an unknown pneumonia in the hospital he worked in. So there were several cases in the hospitals that I didn't see Worobey addressing.
And he soon drops the other market as a spillover site:
However, the earliest known lineage A genomes have close geographical connections to Huanan Market: one from a patient (age and gender not reported) who stayed in a hotel near Huanan Market in the days before illness onset in December (15) and the other from the 62-year-old husband in cluster 1 who visited Yangchahu Market, just a few blocks north of Huanan Market (1), and lived just to the south (see the figure). Therefore, if lineage A had a separate animal origin from lineage B, both most likely occurred at Huanan Market, and the association with Yangchahu Market, which does not appear to have sold live mammals, is likely due to community transmission starting in the neighborhoods surrounding Huanan Market.
Sure, and coincidentally the Yangchahu market had not been cleared out and it could be tested. But it turns out there's no evidence there.
Maybe that's the other market the WHO report noted, IIRC they said a drain at another market had tested positive but the report doesn't name the market. This is the report a number of researchers claimed supported the conclusion spillovers occurred at multiple markets in Wuhan. I have asked numerous times in this thread to show us how the WHO report supported that conclusion. So far crickets. But I'm still open to someone finding it in the report.
The reason multiple market sources is important is it supposedly decreases the odds the virus coincidentally emerged where such viruses were being studied.
Of all the gin joints in China ...
Getting back to Worobey:
Thus, 10 of these hospitals’ 19 earliest COVID-19 cases were linked to Huanan Market (∼53%), comparable both to Jinyintan’s 66% (of 41 cases) (4) and to the WHO-China report’s 33% of 168 retrospectively identified cases within Wuhan across December 2019 (1). ...
... there was a genuine preponderance of early COVID-19 cases associated with Huanan Market.
He goes on discussing how all the cases not connected to the market could have been infected by the virus circulating undetected.
Sure, but in addition, the cluster of cases could also be explained by a super-spreader event at the market.